By Sarah Steingrüber In October of this year, I attended the World Health Summit in Berlin. During a session on Access to Medicines the conversation landed on a critical barrier to providing universal access, namely, where is the money going to come from? There was subsequently a call made out by the panel to get...
Press Release
November 27, 2018
27th November 2018, London – A new media investigation has found unsafe medical devices being used on patients in the UK highlighting both the urgent need for transparency around medical device development, as well as greater awareness of the potentially dire consequences when transparency is lacking. The investigation found that due to a lax system of...
Press Release
September 14, 2018
14th September 2018, London – Transparency International is deeply concerned by new data that shows thousands of clinical trials in Europe are failing to publish their results in an effective and timely manner. The research, conducted by researchers at Oxford University and published in the British Medical Journal, found that almost half of all European-registered...
By Sarah Steingrüber In early July 2018, the new Italian government proposed a bill to adopt a so-called “Sunshine Act” in order to “[fight] corruption in the health system and maximise transparency in the relationships between companies […] and healthcare providers”. This piece of legislation calls for disclosure of all transfers of value over €10...
Press Release
May 1, 2018
Corruption in Nigerian pharma industry fuelling drugs endemic Pharma firms must do more to root out corruption 1st May 2018 – Powerful cough medicines containing the opioid, codeine, used as a recreational drug, are being sold on the black market by corrupt individuals within big Nigerian pharma companies, according to a new investigation by the...
